{
    "clinical_study": {
        "@rank": "43425", 
        "arm_group": [
            {
                "arm_group_label": "BiCision Arm", 
                "arm_group_type": "Experimental", 
                "description": "Coagulation with BiCision"
            }, 
            {
                "arm_group_label": "Ultracision Arm", 
                "arm_group_type": "Active Comparator", 
                "description": "Coagulation with Ultracision"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is the evaluation of the efficiency and safety of the new, CE-certified\n      thermofu-sion and dissection instrument BiCision\u00ae in comparison with the long established\n      Ultracision\u00ae Har-monic Scalpel(Ethicon)during a  laparoscopic supracervical hysterectomy\n      (LASH)."
        }, 
        "brief_title": "Comparison of BiCision\u00ae Versus UltraCision\u00ae During Laparoscopic Supracervical Hysterectomy (LASH)", 
        "completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Uterine Bleeding Disorders", 
            "Benign Uterine Conditions", 
            "Focus: Comparison of Two Instruments"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Blood Coagulation Disorders", 
                "Hemostatic Disorders", 
                "Hemorrhagic Disorders", 
                "Hemorrhage", 
                "Uterine Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age > 18\n\n          -  gender: female\n\n          -  indication for laparoscopic supracervical hysterectomy with no adnexectomyor other\n             surgery\n\n          -  will and the capability to comply the study requirements\n\n          -  signed informed consent\n\n        Exclusion Criteria:\n\n          -  Invasive malignome in the pelvis\n\n          -  Cardiac pacemaker or implanted defibrilator if no informations are available about\n             the compatibil-ity with RF energy\n\n          -  Abnormal blood parameters (values less than factor 0.8 or more than 1.25 compared to\n             the val-ues of creatinine and standard hemogram)\n\n          -  Abnormal coagulation parameters: PTT > 40 sec. and / or  Quick's-Value< 50% (the use\n             of antiplateletsup to a max. of 100mg/d is no exclusion criteria)\n\n          -  Inability to understand the purpose of the study\n\n          -  status after a laparotomy by a longitudinal incision\n\n          -  intraabdominal adhesions (at the beginning of the surgery \u2265 5 sectioning for\n             adhesiolysis)\n\n          -  open laparoscopy required\n\n          -  different anatomical situations that yields to different surgery requirements\n\n          -  conspicuous  PAP, cervixmyoma or endometriosis of  the rectovaginale space"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01752725", 
            "org_study_id": "04122012"
        }, 
        "intervention": [
            {
                "arm_group_label": "BiCision Arm", 
                "intervention_name": "BiCision\u00ae", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Ultracision Arm", 
                "intervention_name": "Ultracision\u00ae Har-monic Scalpel(Ethicon)", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "supracervical hysterectomy", 
            "vessel sealing", 
            "bipolar electrocoagulation"
        ], 
        "lastchanged_date": "December 14, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "T\u00fcbingen", 
                    "country": "Germany", 
                    "zip": "72076"
                }, 
                "name": "University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of BiCision\u00ae Versus UltraCision\u00ae During Laparoscopic Supracervical Hysterectomy (LASH): A Prospective, Controlled, Randomized, Non-inferiority in Vivo Human Study.", 
        "overall_official": [
            {
                "affiliation": "University Hospital Tuebingen", 
                "last_name": "Diethelm Wallwiener, Professor", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University Hospital Tuebingen", 
                "last_name": "Bernhard Kr\u00e4mer, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary objective is the operation time for each preparation side and instrument needed from the beginning of the removal of the cornual structure of the uterus (uterine cornu) till the completely removal of the parametric tissue directly before removal of the corpus uteri from the cervix.", 
            "measure": "Operation time", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for the duration of hospital stay, an expexted average of 8 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01752725"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Tuebingen", 
            "investigator_full_name": "Bernhard Kraemer", 
            "investigator_title": "Executive / Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University Hospital Tuebingen", 
        "sponsors": {
            "collaborator": {
                "agency": "ERBE Elektromedizin GmbH", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University Hospital Tuebingen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}